How will Pharmaniaga address its PN17 status?

Question

Accepted Answer

Pharmaniaga to Focus on Financial Strengthening and Business Viability to Address PN17 Status

Pharmaniaga Bhd is committed to developing and implementing a regularization plan to address its PN17 status, as required by Bursa Malaysia. This plan will centre on enhancing the company's financial position while ensuring the continued viability and growth prospects of its core business operations. The company has assured stakeholders that its operational activities, encompassing both government concession business and private sector dealings, will remain uninterrupted throughout this process.
Regularisation Plan Focus

The core objective of Pharmaniaga's upcoming regularization plan is to fortify its financial standing. Alongside this, the plan aims to guarantee that the group's essential business activities are not only sustained but also positioned for future growth. This dual focus is intended to restore market confidence and ensure the long-term health of the company.
Continued Operational Integrity

Pharmaniaga has explicitly stated that its day-to-day operations will not be affected by its PN17 classification. This includes its concession business arrangements with the Ministry of Health and its non-concession business activities within the private sector. The company is dedicated to maintaining the continuity and effectiveness of these operations.
Commitment to Financial Obligations

A key component of Pharmaniaga's strategy involves upholding its financial commitments. The group has affirmed its dedication to meeting all its obligations to lenders and other financial institutions. Furthermore, it is actively working on the formulation of an optimal cash flow plan to manage its financial resources effectively.

Reading history

Hide →

This history is cleared when the page is closed.

How will Pharmaniaga address its PN17 status?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends